Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR: A Randomized Controlled Trial

PURPOSE: To evaluate efficacy and safety of intravitreal injections of aflibercept (IVT-AFL) treat-and-extend (T&E) dosing regimens in treatment-naïve patients with exudative age-related macular degeneration (AMD). METHODS: Adults aged at least 50 years old with exudative AMD and best-corrected...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohji, Masahito, Takahashi, Kanji, Okada, Annabelle A., Kobayashi, Masato, Matsuda, Yoshimi, Terano, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089719/
https://www.ncbi.nlm.nih.gov/pubmed/32016788
http://dx.doi.org/10.1007/s12325-020-01236-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089719/
https://www.ncbi.nlm.nih.gov/pubmed/32016788
http://dx.doi.org/10.1007/s12325-020-01236-x

Ejemplares similares